The observed significant decrease in HSPA1A expression in liver samples exposed to benzo[a]pyrene (B[a]P) and NASH suggests a potential protective response by hepatocytes to mitigate the harmful effects of B[a]P exposure and restore normal cellular functioning. Here, HSPA1A is linked to metabolic dysfunction-associated steatohepatitis.